相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro
Ilkka Paatero et al.
GYNECOLOGIC ONCOLOGY (2013)
Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
Jing Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Function of ERBB4 is determined by alternative splicing
Ville Veikkolainen et al.
CELL CYCLE (2011)
Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines
Christopher P. Mill et al.
EXPERIMENTAL CELL RESEARCH (2011)
A growing family Adding mutated Erbb4 as a novel cancer target
Udo Rudloff et al.
CELL CYCLE (2010)
Potential of ErbB4 antibodies for cancer therapy
Maija Hollmen et al.
FUTURE ONCOLOGY (2010)
Anti-tumor activity of splice-switching oligonucleotides
John A. Bauman et al.
NUCLEIC ACIDS RESEARCH (2010)
A Therapeutic Opportunity in Melanoma: ErbB4 Makes a Mark on Skin
Jeff Settleman
CANCER CELL (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells
Fenghua Zeng et al.
FASEB JOURNAL (2009)
ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo
Rebecca S. Muraoka-Cook et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
Todd D. Prickett et al.
NATURE GENETICS (2009)
Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms
M. Hollmen et al.
ONCOGENE (2009)
Mutated ERBB4: a novel drug target in metastatic melanoma?
Kari Kurppa et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
Saovaros Svasti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The status and role of ErbB receptors in human cancer
I. Ueberall et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
An endogenous TNF-α antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models
Maria A. Graziewicz et al.
MOLECULAR THERAPY (2008)
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms
Maria Sundvall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular differentiation of early and late stage laryngeal squamous cell carcinoma
Ozlen Saglam et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
Erb4 isofors selectively regulate growth factor-induced adin-darby canine kidney cell tubulogenesis
Fenghua Zeng et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains
M. Sundvall et al.
ONCOGENE (2007)
The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation
Jasminka Omerovic et al.
FASEB JOURNAL (2007)
Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
Bernard Khoo et al.
BMC MOLECULAR BIOLOGY (2007)
Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets
E. Ferretti et al.
ONCOGENE (2006)
Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice
Jennifer Roberts et al.
MOLECULAR THERAPY (2006)
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells
Anjali Naresh et al.
CANCER RESEARCH (2006)
Analysis of prostate-specific membrane antigen splice variants in LNCap cells
Tiffany Williams et al.
OLIGONUCLEOTIDES (2006)
Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical. outcomes after radiation therapy in carcinoma of the cervix
CM Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function
RI Aqeilan et al.
CANCER RESEARCH (2005)
Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome
P Scaffidi et al.
NATURE MEDICINE (2005)
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
TT Junttila et al.
CANCER RESEARCH (2005)
Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
A Gschwind et al.
NATURE REVIEWS CANCER (2004)
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
AA Memon et al.
BRITISH JOURNAL OF CANCER (2004)
Ectodomain cleavage of ErbB-4 - Characterization of the cleavage site and m80 fragment
QC Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
P Sazani et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
ErbB-4: mechanism of action and biology
G Carpenter
EXPERIMENTAL CELL RESEARCH (2003)
Correction of disease-associated exon skipping by synthetic exon-specific activators
L Cartegni et al.
NATURE STRUCTURAL BIOLOGY (2003)
Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery
JC Lee et al.
EUROPEAN JOURNAL OF CANCER (2002)
γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase
CY Ni et al.
SCIENCE (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4
C Rio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis
V Kainulainen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
